International Stem Cell Corp - ESG Rating & Company Profile powered by AI
The Sustainability assessment for International Stem Cell Corp represents its transparency towards the UN Sustainable Development Goals. This analysis of International Stem Cell Corp leverages data from across the internet as well as from public documents by International Stem Cell Corp. Other corporations in the scoring industry group for International Stem Cell Corp are displayedin the table.
International Stem Cell Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 8.0 and governance score of 5.3.
7.1
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 217 | Takara Bio Inc | 7.2 | High |
| 217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
| 224 | International Stem Cell Corp | 7.1 | High |
| 224 | Celularity Inc | 7.1 | High |
| 224 | Bilcare Ltd | 7.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does International Stem Cell Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes International Stem Cell Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes International Stem Cell Corp report the average age of the workforce?
Sign up for free to unlockDoes International Stem Cell Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes International Stem Cell Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes International Stem Cell Corp disclose cybersecurity risks?
Sign up for free to unlockDoes International Stem Cell Corp offer flexible work?
Sign up for free to unlockDoes International Stem Cell Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes International Stem Cell Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes International Stem Cell Corp conduct supply chain audits?
Sign up for free to unlockDoes International Stem Cell Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes International Stem Cell Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes International Stem Cell Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes International Stem Cell Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes International Stem Cell Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes International Stem Cell Corp disclose water use targets?
Sign up for free to unlockDoes International Stem Cell Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid International Stem Cell Corp have a product recall in the last two years?
Sign up for free to unlockDoes International Stem Cell Corp disclose incidents of discrimination?
Sign up for free to unlockDoes International Stem Cell Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas International Stem Cell Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes International Stem Cell Corp disclose parental leave metrics?
Sign up for free to unlockDoes International Stem Cell Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes International Stem Cell Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes International Stem Cell Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes International Stem Cell Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes International Stem Cell Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes International Stem Cell Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs International Stem Cell Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes International Stem Cell Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes International Stem Cell Corp disclose its waste policy?
Sign up for free to unlockDoes International Stem Cell Corp report according to TCFD requirements?
Sign up for free to unlockDoes International Stem Cell Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes International Stem Cell Corp disclose energy use targets?
Sign up for free to unlockDoes International Stem Cell Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes International Stem Cell Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for International Stem Cell Corp
These potential risks are based on the size, segment and geographies of the company.
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. The company sells skincare products through a website and professional channels; and human cell culture products through its sales force, OEM partners, and brand distributors. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.